Birth control and HIV prevention pill study for women
Part of Immune system & allergy, Infections clinical trials.
This study tests how well two different pill combinations work together to prevent HIV and pregnancy. You'll take daily birth control pills and daily HIV prevention pills, and researchers will check your health regularly for about a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 16 and 39 years old.
- You have had vaginal sex in the last 3 months and could become pregnant.
- You are not pregnant, not planning pregnancy in the next year, and willing to take daily birth control pills.
- You are HIV-negative and willing to take daily oral PrEP (pills that prevent HIV).
- You have normal kidney function and no infections that would make the pills unsafe (like hepatitis B or C).
- You have not had a bad reaction to PrEP in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well HIV treatment (ART) and a hormonal birth control method (DMPA shot or implant) work together, using small blood samples. It may help ensure safer, more effective HIV care and contraception for young women.
This study tests a long-acting HIV prevention shot (Cabotegravir) or a vaginal ring (DapiRing) along with sexual health services for young people. It aims to find the best way to prevent HIV and support overall health.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This research studies how two types of long-acting birth control (a shot called cabotegravir and an implant) work in your body after pregnancy, and how they interact with HIV prevention or treatment. The study helps doctors understand the best doses and timing for women like you.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.